Trial
NCT00360087
A Study of Patients Having Pulmonary Hypertension Associated With Sickle Cell Disease and Completing an ASSET Study
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Actelion
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
Condition
Pulmonary Hypertension
Intervention
Bosentan
Why stopped
Slow enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-02-03